By M. Mannig. Lyme Academy of Fine Arts.
Trachoma Cases of follicular or inflammatory trachoma 2 Blindness Corrected visual acuity in the better eye of less than 3/60 Low vision Corrected visual acuity in the better eye of less than 6/18 but better than or equal to 3/60 A14a buy terbinafine 250mg mastercard. Lower respiratory infections 2 Episodes Episode of lower respiratory infection Chronic sequelae Includes bronchiectasis and impaired lung function as measured by a decrease in forced expiratory volume B2 discount terbinafine 250 mg with amex. Upper respiratory infections 2 Episodes Episode of upper respiratory infection Pharyngitis Inflammation of the pharynx B3 quality terbinafine 250mg. Otitis media Inflammation of the middle ear 0 Episodes Episodes of acute otitis media Deafness At least moderate impairment cheap terbinafine 250mg with amex, where person is able to hear and repeat words using raised voice at 1 meter order terbinafine 250mg, resulting from otitis media C1. Maternal hemorrhage 2 Episodes All episodes of antepartum and postpartum hemorrhage Severe anemia Blood hemoglobin level 10 mg/dl following postpartum hemorrhage (Continues on the following page. Maternal sepsis 2 Episodes Major puerperal infection, excluding infection following abortion, minor genital tract infection following delivery, and urinary tract infections following delivery Infertility Failure to conceive again after a previous conception (secondary infertility), caused by maternal sepsis C3. Hypertensive disorders of pregnancy— Includes pre-eclampsia and eclampsia 2 episodes C4. Obstructed labor 2 Episodes Labor with no advance of the presenting part of the fetus despite strong uterine contractions Cesarean section for obstructed labor Cases of obstructed labor for which cesarean section has been performed Stress incontinence Cases with leaking of urine during coughing or sneezing Rectovaginal fistula Cases with a communication between the vaginal wall and the bladder/rectum resulting from obstructed labor C5. Abortion 2 Episodes Episodes of unsafe abortion (termination of an unwanted pregnancy either by persons lacking the necessary skills or in an environment lacking the necessary standards or both) Infertility Failure to conceive following unsafe abortion Reproductive tract infection Cases of reproductive tract infection resulting from unsafe abortion D1. Low birthweight—all sequelae Birthweight below 2,500 g, including small-for-gestational-age infants and 2 premature infants (all developmental sequelae due to low birthweight have been clustered into one outcome, which includes cerebral palsy, mental retardation, epilepsy, hearing loss, and vision loss) D2. Birth asphyxia and birth trauma—all All developmental sequelae due to birth asphyxia and birth trauma have been 2 sequelae clustered into one outcome, which includes cerebral palsy, mental retardation, epilepsy, hearing loss, and vision loss E1. Protein-energy malnutrition 2 Wasting Observed weight for height at least 2 standard deviations below the mean for children ages 0–5 Stunting Observed height for age at least 2 standard deviations below the mean for children ages 0–5 Developmental disability Limited physical and mental ability to perform most activities in all of the following areas: recreation, education, procreation, or occupation E2. Vitamin A deficiency 2 Xerophthalmia All ocular manifestations of vitamin A deficiency: night blindness, Bitot’s spots, corneal xerosis, corneal ulceration, and corneal scarring Corneal scar Permanent corneal scar resulting from corneal ulceration due to vitamin A deficiency and potentially leading to blindness 112 | Global Burden of Disease and Risk Factors | Colin D. Malignant neoplasms sequelae 2 Diagnosis and primary therapy Chemotherapy, radiotherapy, surgery Control Clinical observation during control/remission phase Preterminal (metastasis) Metastatic dissemination of the disease Therminal Therminal stage prior to death Mastectomy Mastectomy in five-year breast cancer survivor Infertility Infertility in five-year survivor of cervical, uterine, or ovarian cancer Incontinence or impotence Incontinence or impotence in five-year survivor of prostate cancer Stoma Stoma in five-year survivor of digestive system cancer C. Alzheimer’s and other dementias—cases Mild, moderate, and severe Alzheimer’s disease; senility; and other dementias 2 E7. Parkinson’s disease—cases Cases meeting clinical criteria for Parkinson’s disease 1 E8. Multiple sclerosis—cases Cases of chronic or intermittent relapsing multiple sclerosis 1 (Continues on the following page. Glaucoma Cases of primary angle closure glaucoma and primary open angle glaucoma 2 Low vision Corrected visual acuity in the better eye of less than 6/18 but better than or equal to 3/60 Blindness Corrected visual acuity in the better eye of less than 3/60 F2. Cataracts Cases of senile cataract causing progressive visual impairment 2 Low vision Corrected visual acuity in the better eye of less than 6/18 but better than or equal to 3/60 Blindness Corrected visual acuity in the better eye of less than 3/60 F3. Vision disorders, age-related Low vision or blindness due to macular degeneration, refractive errors, or other 2 age-related causes; excludes sight loss due to congenital causes, other diseases, or injury Low vision Corrected visual acuity in the better eye of less than 6/18 but better than or equal to 3/60 Blindness Corrected visual acuity in the better eye of less than 3/60 F4. Rheumatic heart disease Symptomatic cases of congestive heart failure due to rheumatic heart disease 0 G2. Hypertensive heart disease Symptomatic cases of congestive heart failure due to hypertensive heart disease 0 114 | Global Burden of Disease and Risk Factors | Colin D. Inflammatory heart diseases 0 Myocarditis Symptomatic cases of congestive heart failure due to myocarditis Pericarditis Symptomatic cases of congestive heart failure due to pericarditis Endocarditis Symptomatic cases of congestive heart failure due to endocarditis Cardiomyopathy Symptomatic cases of congestive heart failure due to cardiomyopathy H1. Peptic ulcer disease Individuals with peptic ulcers, most of whom have recurrent intermittent symptoms 0 Cases with antibiotic treatment Active gastric or peptic duodenal ulcer receiving appropriate antibiotic treatment Cases not treated with antibiotic Other active gastric or peptic duodenal ulcer; includes untreated cases and cases receiving symptomatic treatment I2. Cirrhosis of the liver—symptomatic Individuals with symptomatic cirrhosis 0 cases I3. Nephritis and nephrosis 0 Acute glomerulonephritis Acute episode of glomerulonephritis End-stage renal disease End-stage renal failure with or without dialysis, excluding diabetic nephropathy and nephropathy due to cancers, congenital conditions, and injury J2. Benign prostatic hypertrophy— Individuals with some, albeit intermittent, symptoms from benign prostatic 0 symptomatic cases hypertrophy L1. Osteoarthritis 2 Hip Symptomatic osteoarthritis of the hip, radiologically confirmed as Kellgren- Lawrence grade 2–4 Knee Symptomatic osteoarthritis of the knee, radiologically confirmed as Kellgren- Lawrence grade 2–4 L3. Low back pain 1 Episode of limiting low back pain Acute episode of low back pain resulting in moderate or greater limitations to mobility and usual activities; excludes low back pain due to intervertebral disc displacement or herniation, and low back pain that does not result in some limitations to mobility and usual activities (Continues on the following page. Abdominal wall defect—cases Live-born cases with exomphalos or gastroschisis 0 M2. Cleft lip—cases Live-born cases, includes individuals who have had surgical correction 0 M5. Cleft palate—cases Live-born cases, includes individuals who have had surgical correction 0 M6. Congenital heart anomalies—cases Live-born cases with major congenital malformations of the heart 0 M10. Spina bifida—cases Live-born cases with spina bifida aperta (low, medium, or high level) 0 N1. Dental caries—episodes Episodes per person, not per tooth, quadrant, or sextant 0 N2. Injuries External cause categories Includes injury severe enough to warrant medical attention or that leads immedi- ately to death. In other words, injuries that are severe enough that if an individual had access to a medical facility he or she would seek attentionc 2 A1.
For example discount terbinafine 250 mg online, if you have a history of fainting upon exposure to blood generic terbinafine 250 mg without prescription, your belief that you’re likely to faint the next time you see blood may indeed be a realistic one cheap terbinafine 250 mg on-line. For example buy terbinafine 250 mg low price, although it is true that dental treatment is sometimes uncomfortable terbinafine 250mg with visa, many people overestimate the amount of pain they’ll experience next time they go to the dentist. People who fear fainting during a blood test may overesti- mate just how terrible it would be to actually faint. It is these exaggerated or unrealistic beliefs and assumptions that this chapter is meant to help change. The strategies described in this chapter are often referred to as cognitive strategies or cognitive therapy. The word “cognitive” simply refers to processes involving thought, such as ruminating, thinking, imagining, remem- bering, paying attention, and related processes. Cognitive therapy involves helping people identify their patterns of negative thinking and replace negative thoughts with more balanced or realistic thoughts that are based on a thorough analysis of the evidence concerning the beliefs. Note that almost all studies on the treatment of blood and needle phobias are based on the exposure strategies discussed in chapter 5 (often combined with the tension exercises described in chapter 6 for those with a history of fainting). Most experts believe that exposure to a feared situation is the most powerful way to combat fear. The techniques described in this chapter are not meant to be used instead of the exposure-based strat- egies. Rather, they are meant to be used in addition to exposure, or perhaps to give you the courage you need to do the exposure exercises. For example, exposure may well be effective because it provides evidence that challenges anxious beliefs and assumptions. In fact, avoiding feared situations tends to increase the intensity of negative thinking. For example, Kent (1985) found that people with dental anxiety who visit the dentist infrequently are more likely to predict that their next visit to the dentist will be a negative experience, com- pared to people with the same level of dental anxiety who visit the dentist on a regular basis (probably because they believe they will need more extensive treatment). The effectiveness of the cognitive strategies described in this chapter is well established for certain types of anxiety problems, including panic disorder, in which people have rushes of panic out of the blue, and social anxiety disorder, in which people experience anxi- ety in social or performance situations (see Antony and Swinson 2000). However, unlike exposure-based treat- ments, cognitive therapies have not been studied much for fears of blood, needles, doctors, and dentists. In fact, there have been no large-scale studies on the effective- ness of cognitive therapy on blood and needle phobias in particular, though some initial case studies suggest that these strategies may be useful (Panzarella and Garlipp 1999; Thompson 1999). In the case of dental phobia, however, there are a few larger, well-controlled studies showing that changing your thoughts (often in addition to exposure) can lead to a reduction in dental anxiety (de Jongh et al. In many cases, the assumptions, perceptions, and predictions that contribute to fear occur very quickly, often outside of our awareness. In fact, the fear we experience in reaction to the situations we fear may seem to occur almost auto- matically. However, that doesn’t mean that our fear is not triggered by our perceptions of the situation. There are many examples of how our perceptions can influence our behavior even when we’re not aware that this is happening. When you first learn to drive, you need to think carefully about every little thing you do. You must pay attention to what’s happening on the road in front of you, but you also need to check your rearview mirror on occa- sion and attend to what’s happening off to the side. You may also check your speedometer, talk to the person in the passenger seat, make sure your feet are on the right pedals, and remember to change gears when necessary. However, over time, driving becomes second nature, and you can do many of these things automatically, paying only minimal attention. That doesn’t mean you aren’t interpreting your surroundings and making decisions based on your percep- tions. The fear you experience upon exposure to blood, needles, doctors, or dentists may be quick and automatic, but it’s probably changing your thoughts 119 related to your perception that the situation is dangerous or threatening in some way. The first step in changing your thoughts is to figure out what they are in the first place. It may be difficult to identify your thoughts at first, but it should become easier with practice. Typically, people with phobias experience anxious thoughts and predictions about the objects and situations they fear. However, they may also experience anxious thoughts about their own anxious reactions (panic attacks, fainting, dizziness, and the like). Here are some examples of such predictions: 7 I’ll experience intense pain at the dentist’s. For example, people with height pho- bias often fear getting dizzy in high places, people with a fear of enclosed places often are fearful of experiencing breathlessness in enclosed places, and people with a fear of public speaking often fear experiencing signs of anxi- ety that might be noticeable to others, such as blushing, sweating, or shaking.
Splenectomized patients must be informed about the risk of infection (encapsulated microorganisms) (splenectomized patient card) and be vaccinated against pneumoccocus infection every 5 years (recommended immunization schedule) buy discount terbinafine 250mg on line. If splenectomy was not programmed terbinafine 250mg fast delivery, vaccination must be performed even if the response is uncertain and less intense generic terbinafine 250mg mastercard. Outside an emergency 250 mg terbinafine mastercard, the patient may be operated after correcting biochemical parameters (Full blood count – coagulation values) generic terbinafine 250mg on line. Generally, a clinical examination is performed: In untreated patients: every 6 months if there is no worsening; In treated patients: every 3 months at the start of treatment; every 6 months when treatment goals have been reached; after each change in dosage. Coagulation status Blood coagulation tests should be performed: In untreated patients: every 12 months; In treated patients, if there was an abnormality in the baseline examination: – every 3 months at the start of treatment until normal values are restored; – then every 12 months; – after each change in dosage. These tests should be performed: In untreated patients: every 6 to 12 months; In treated patients: – every 3 months at the start of treatment; – every 6 to 12 months when treatment goals have been reached; – after each change in the dosage. Then: if there is a satisfactory clinical improvement with normal biomarkers: Only annual surveillance of chitotriosidase is justified; Every 3 months if clinical improvement is insufficient. Additional assays should be carried out after changes in the dosage or a specific clinical event (to be reported to the laboratory conducting the assay). Assays of anti-imiglucerase antibodies: Every 6 months during the first 18 months of treatment, then discontinuation; In the case of immunoallergic reaction(s); When there is lack of treatment efficacy (very rare cases of neutralizing antibodies). Radiography – In untreated patients: Only in the case of an intercurrent bone event. It may however be used to measure the thickness of cortical bone after a fracture. Pregnancy in Ciana G, Addobbati R, Tamaro Gaucher disease in the era of G, Leopaldi A, Nevyjel M, enzyme replacement therapy. The role of the iminosugar The metabolic and molecular N-butyldeoxynojirimycin basis of inherited disease. Nutritional Nature of inherited enzyme management during initiation of deficiency. Bone density changes with and therapeutic aspects of enzyme therapy for Gaucher Gaucher disease. Third case of Tsur V, Farber B, Glaser Y, Gaucher disease with sap-C Hadas-Halpern I, et al. J progressive calcification of heart Inherit Metab Dis valves and unique genotype. Hematologica; 2007 (92);215-221 Gillis S, Hyam E, Abrahamov A, Elstein D, Zimran A. Platelet Elstein D, Abrahamov A, Dweck function abnormalities in Gaucher A, Hadas-Halpern I, Zimran A. Enzyme therapy partly restored by enzyme in Gaucher disease type 1: supplementation therapy. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Guidance on the use of miglustat for treating patients with type 1 Gaucher disease. A Strategic Plan for the Elimination of Tuberculosis in the United States was published in 1989 and reassessed in 1999 to identify the actions necessary to achieve elimination. Although rates continued to decline from 2003 through 2008, it was at a much slower rate. It is important to focus on local epidemiology to identify trends in individual states or regions. While national trends indicate that there has been a decline in the overall number of cases since 1993, cases continue to be reported. Overall, the number of cases in foreign-born persons has remained virtually level with approximately 7,000– 8,000 cases each year, until 2009 when the number dropped to 6,854. Tat decreasing trend continued in 2011 with the number of cases in foreign-born persons dropping to 6,510. The number of states with 25%-49% of cases among foreign-born persons decreased from 14 states in 2001 to 11 states in 2011. However, the number of states that had 50% or more of their cases among foreign-born persons increased from 23 states in 2001 to 34 states in 2011. Seven countries accounted for 61% of the total cases in foreign-born persons in 2011 (Table 1. Rates also declined in the following racial/ ethnic groups: among non-Hispanic blacks or African-Americans, from 11. Rates decreased among Native Hawaiian or Other Pacifc Islanders after two years of increase since 2008, from 16. Rates declined by at least 22% among non-Hispanic blacks or African Americans, Hispanics, American Indians and Alaska Natives, and non-Hispanic whites from 2003 to 2011.